Further studies suggest that KLF4’s inhibition of cancer may be mediated by downregulating the TGF-β1-mediated extracellular regulated protein kinases (ERK)/JNK/NF-κB signaling pathway (22). The gene discussed is NFKB1; the disease is cancer.